Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X):a randomised, placebo-controlled trial

MLA

Deodhar, Atul, et al. “Ixekizumab for Patients with Non-Radiographic Axial Spondyloarthritis (COAST-X):A Randomised, Placebo-Controlled Trial.” Deodhar , A , van Der Heijde , D , Gensler , L S , Kim , T H , Maksymowych , W P , Østergaard , M , Poddubnyy , D , Marzo-Ortega , H , Bessette , L , Tomita , T , Leung , A , Hojnik , M , Gallo , G , Li , X , Adams , D , Carlier , H , Sieper , J , Morin , F , Rahman , P , Ariel , F , Berman , A , Carrio , J , Lucero , E , Cocco , J M , Hidalgo , R P , Velasco , J , Viola , D O , Grisar , J , Resch , H , Scheinecker , C , Melazzi , A C , Roimicher , L , Scotton , A S , Rodriguez , A A B , Molina , F F C , Barragan , S D , Skinner , C M , Tena , C F P , Remus , C R R , Rodriguez , J C R , Hong , S J , Kang , S W , Lee , C K , Lee , E B , Lee , S H , Park , M C , Lee , S H , Dokoupilova , E , Dvorak , Z , Malcova , M & COAST-X Study Group 2020 , ’ Ixekizumab for Patients with Non-Radiographic Axial Spondyloarthritis (COAST-X) : A Randomised, Placebo-Controlled Trial ’ , The Lancet , Vol. 395 , No. 10217 , Pp. 53-64 , 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322759848&authtype=sso&custid=ns315887.

APA

Deodhar, A., van der Heijde, D., Gensler, L. S., Kim, T. H., Maksymowych, W. P., Østergaard, M., Poddubnyy, D., Marzo-Ortega, H., Bessette, L., Tomita, T., Leung, A., Hojnik, M., Gallo, G., Li, X., Adams, D., Carlier, H., Sieper, J., Morin, F., Rahman, P., … Malcova, M. (2020). Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X):a randomised, placebo-controlled trial. Deodhar , A , van Der Heijde , D , Gensler , L S , Kim , T H , Maksymowych , W P , Østergaard , M , Poddubnyy , D , Marzo-Ortega , H , Bessette , L , Tomita , T , Leung , A , Hojnik , M , Gallo , G , Li , X , Adams , D , Carlier , H , Sieper , J , Morin , F , Rahman , P , Ariel , F , Berman , A , Carrio , J , Lucero , E , Cocco , J M , Hidalgo , R P , Velasco , J , Viola , D O , Grisar , J , Resch , H , Scheinecker , C , Melazzi , A C , Roimicher , L , Scotton , A S , Rodriguez , A A B , Molina , F F C , Barragan , S D , Skinner , C M , Tena , C F P , Remus , C R R , Rodriguez , J C R , Hong , S J , Kang , S W , Lee , C K , Lee , E B , Lee , S H , Park , M C , Lee , S H , Dokoupilova , E , Dvorak , Z , Malcova , M & COAST-X Study Group 2020 , ’ Ixekizumab for Patients with Non-Radiographic Axial Spondyloarthritis (COAST-X) : A Randomised, Placebo-Controlled Trial ’ , The Lancet , Vol. 395 , No. 10217 , Pp. 53-64 .

Chicago

Deodhar, Atul, Désirée van der Heijde, Lianne S. Gensler, Tae Hwan Kim, Walter P. Maksymowych, Mikkel Østergaard, Denis Poddubnyy, et al. 2020. “Ixekizumab for Patients with Non-Radiographic Axial Spondyloarthritis (COAST-X):A Randomised, Placebo-Controlled Trial.” Deodhar , A , van Der Heijde , D , Gensler , L S , Kim , T H , Maksymowych , W P , Østergaard , M , Poddubnyy , D , Marzo-Ortega , H , Bessette , L , Tomita , T , Leung , A , Hojnik , M , Gallo , G , Li , X , Adams , D , Carlier , H , Sieper , J , Morin , F , Rahman , P , Ariel , F , Berman , A , Carrio , J , Lucero , E , Cocco , J M , Hidalgo , R P , Velasco , J , Viola , D O , Grisar , J , Resch , H , Scheinecker , C , Melazzi , A C , Roimicher , L , Scotton , A S , Rodriguez , A A B , Molina , F F C , Barragan , S D , Skinner , C M , Tena , C F P , Remus , C R R , Rodriguez , J C R , Hong , S J , Kang , S W , Lee , C K , Lee , E B , Lee , S H , Park , M C , Lee , S H , Dokoupilova , E , Dvorak , Z , Malcova , M & COAST-X Study Group 2020 , ’ Ixekizumab for Patients with Non-Radiographic Axial Spondyloarthritis (COAST-X) : A Randomised, Placebo-Controlled Trial ’ , The Lancet , Vol. 395 , No. 10217 , Pp. 53-64 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322759848&authtype=sso&custid=ns315887.